Rizzo A.; Ricci A.D.; Brandi G., Combination therapy of dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer, «HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL», 2021, 20, pp. 506 - 507 [replica/breve intervento]
Filippini D.M.; Di Federico A.; Lenzi B.; Nobili E.; Brocchi S.; Malvi D.; Brandi G., Critical diagnostic delay associated with unusual presentation of hepatocellular carcinoma (Hcc) with orbital metastases: A case report, «ANNALS OF PALLIATIVE MEDICINE», 2021, 10, pp. 8474 - 8478 [articolo]Open Access
Rizzo A.; Ricci A.D.; Brandi G., Detecting and targeting NTRK gene fusions in cholangiocarcinoma: news and perspectives, «EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT», 2021, 6, pp. 225 - 227 [articolo]
Ricci A.D.; Rizzo A.; Brandi G., DNA damage response alterations in gastric cancer: Knocking down a new wall, «FUTURE ONCOLOGY», 2021, 17, pp. 865 - 868 [articolo]
Rizzo A.; Ricci A.D.; Brandi G., Durvalumab: an investigational anti-PD-L1 antibody for the treatment of biliary tract cancer, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2021, 30, pp. 343 - 350 [articolo]
Kudo M.; Galle P.R.; Brandi G.; Kang Y.-K.; Yen C.-J.; Finn R.S.; Llovet J.M.; Assenat E.; Merle P.; Chan S.L.; Palmer D.H.; Ikeda M.; Yamashita T.; Vogel A.; Huang Y.-H.; Abada P.B.; Yoshikawa R.; Shinozaki K.; Wang C.; Widau R.C.; Zhu A.X., Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2, «JHEP REPORTS», 2021, 3, Article number: 100215, pp. 1 - 12 [articolo]Open Access
Maria Massucci; Veronica Mollica; Alessandro Rizzo; Laura Ventrella; Ilaria Maggio; Lisa Manuzzi; Lidia Gatto; Giovanni Brandi; Francesco Massari, Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report, «MEDICINES», 2021, 8, Article number: 5, pp. 1 - 4 [articolo]Open Access
Rizzo A.; Ricci A.D.; Bonucci C.; Tober N.; Palloni A.; Frega G.; Brandi G., Experimental HER2- targeted therapies for biliary tract cancer, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2021, 30, pp. 389 - 399 [articolo]
Rizzo A.; Ricci A.D.; Frega G.; Di Federico A.; Brandi G., FGFR inhibitors in elderly patients with advanced biliary tract cancer: an unsolved issue, «EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY», 2021, 15, pp. 567 - 574 [articolo]
Rizzo A.; Brandi G., First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: “And Yet It Moves!”, «CANCER TREATMENT AND RESEARCH COMMUNICATIONS», 2021, 27, pp. 1 - 7 [articolo]Open Access
Rizzo A.; Ricci A.D.; Gadaleta-Caldarola G.; Brandi G., First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges, «EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY», 2021, 15, pp. 1245 - 1251 [articolo]
Rizzo A.; Ricci A.D.; Brandi G., Futibatinib, an investigational agent for the treatment of intrahepatic cholangiocarcinoma: evidence to date and future perspectives, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2021, 30, pp. 317 - 324 [articolo]
Di Federico A.; Tateo V.; Parisi C.; Formica F.; Carloni R.; Frega G.; Rizzo A.; Ricci D.; Di Marco M.; Palloni A.; Brandi G., Hacking pancreatic cancer: Present and future of personalized medicine, «PHARMACEUTICALS», 2021, 14, Article number: 677, pp. 1 - 19 [articolo]Open Access
Ravaioli Matteo; Brandi Giovanni; Siniscalchi Antonio; Renzulli Matteo; Bonatti Chiara; Fallani Guido; Prosperi Enrico; Serenari Matteo; Germinario Giuliana.; Del Gaudio Massimo; Zanfi Chiara; Odaldi Federica; Bertuzzo Valentina Rosa; Pasqualini Eddi; Maroni Lorenzo; Frascaroli Giacomo; Rossetto Anna; Morelli Maria Cristina; Vizioli Luca; Serra Carla; Sangiorgi Gabriela; D'Errico Antonia; Contedini Federico; Cescon Matteo, Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation, «AMERICAN JOURNAL OF TRANSPLANTATION», 2021, 21, pp. 870 - 875 [articolo]Open Access
G. Frega, O. Kepp, D. Turchetti, A. Rizzo, M.A. Pantaleo, G. Brandi, Hypothesis on the possible relevance of the immunogenic cell death in the treatment of gestational trophoblastic neoplasms, «TRANSLATIONAL ONCOLOGY», 2021, 14, Article number: 101224, pp. 1 - 3 [articolo]Open Access
